市場調查報告書

全球獸藥市場(2020-2026)

Global Veterinary Drug Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949602
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球獸藥市場(2020-2026) Global Veterinary Drug Market 2020-2026
出版日期: 2020年06月18日內容資訊: 英文
簡介

在2020年至2026年的預測期內,獸藥市場的複合年增長率預計約為5.5%。寵物的採用增加,人畜共患病的可能性增加,肉類和奶製品的消費增加是全球市場增長的主要驅動力。此外,公司推出的新藥數量不斷增加,藥品在線訪問以及動物健康基礎設施的改善是全球市場增長的其他推動力。

全球獸藥市場是按動物,類型和給藥途徑細分的。按動物劃分,市場進一步分為牲畜,同伴和其他。在預測期內,預計伴侶動物將更好地為其主人服務,並將擁有更大的市場份額。按類型劃分,市場進一步分為抗寄生蟲,抗炎,抗感染等。通過給藥途徑,有口服,注射和局部給藥。口服途徑在市場上佔有很大的市場份額。

獸藥市場也按地區進行了調查,分為北美,歐洲,亞太地區和世界其他地區(RoW)。預計在預測期內,北美將佔有很大的市場份額。此外,由於新興國家寵物繁殖的增加和動物保健基礎設施的增加,預計亞太地區的寵物將有良好的增長。

獸藥市場是一個零散的市場,但很大的市場由少數公司主導。市場上的主要參與者包括Zoetis、Inc., Bayer AG,BOEHRINGER Ingelheim International GmbH,Ceva Sante Animale,Merck & Co., Inc.,Elanco Animal Health Inc.,Vetoquinol S.A.,Virbac S.A. 這些公司的發展戰略包括併購,產品發佈,合作夥伴關係和協作,以便在市場上具有競爭力。

本報告調查了獸藥的全球市場,市場概況,市場增長因素和抑制因素的分析,市場規模趨勢以及按動物,種類,給藥途徑,地區,競爭狀況進行的預測,我們提供系統信息,例如主要公司的概況和市場機會。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 公司份額分析
  • 主要策略分析
  • 主要公司分析
    • Zoetis,Inc.
    • 默克公司
    • 勃林格殷格翰國際有限公司
    • 拜耳公司
    • Elanco Animal Health Inc.

第4章市場決定因素

  • 動機
  • 抑制因子
  • 市場機會

第5章市場細分

  • 按動物
    • 家畜
    • 同伴
    • 其他
  • 按類型
    • 抗寄生蟲
    • 抗炎藥
    • 抗感染
    • 其他
  • 通過管理途徑
      口語
    • 本地
    • 注射
    • 其他

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • Akorn Animal Health, Inc.
  • Bayer AG
  • Bimeda Holdings PLC
  • Biogenesis Bago A.S.
  • BOEHRINGER Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • Hipra S.A.
  • Huvepharma EOOD
  • Hygieia Biological Laboratories
  • Intervet International B.V
  • Merck & Co., Inc.
  • Neogen Corp.
  • Pharmgate LLC
  • Phibro Animal Health Corp.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis, Inc.
目錄
Product Code: OMR2021921

Global Veterinary Drug Market Size, Share & Trends Analysis Report, By Animal (Livestock, Companion, Other), By Type (Anti-Parasitic, Anti-inflammatory, Anti-infective, Others), By Route of Administration (Oral, Injection, Topical, Other) and Forecast, 2020-2026

The veterinary drug market is expected to witness a CAGR of around 5.5% during the forecast period 2020-2026. Increasing the adoption of pet animals, the growing possibility of zoonotic diseases and growth in meat and dairy consumption are the key factors for the growth of the market globally. Besides, growth in new drug launch by the companies, online access to the drugs, improvement in the health infrastructure for animals is some of the other factors driving the growth of the market all across the globe.

The global veterinary drug market is divided on the basis of animal, type, and route of administration. By animal, the market is further divided into livestock, companion, other. During the forecast period, companion animals are expected to have a major market share owing to better facilities reach to them provided by their owners. On the basis of type, the market is further divided into anti-parasitic, anti-inflammatory, anti-infective, and others. By route of administration, the market is divided into oral, injection, and topical. Oral route holds a significant market share in the market

The veterinary drug market is also studied by geography and is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to hold a major market share. Moreover, a lucrative growth is expected in Asia-Pacific due to rising pet ownership, and increasing veterinary healthcare infrastructure in emerging economies.

The veterinary drug market is a fragmented market however a large market is occupied by a few companies. Some of the key players in the market include Zoetis, Inc., Bayer AG, BOEHRINGER Ingelheim International GmbH, Ceva Sante Animale, Merck & Co., Inc., Elanco Animal Health Inc., Vetoquinol S.A., and Virbac S.A. These companies are adopting growth strategies including mergers and acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global veterinary drug market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Veterinary Drug Market Research and Analysis, By Animal
  • Global Veterinary Drug Market Research and Analysis, By Type
  • Global Veterinary Drug Market Research and Analysis, By Route of Administration

The Report Covers:

  • Comprehensive research methodology of the Global Veterinary Drug Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Veterinary drug Market.
  • Insights about market determinants which are stimulating the Global Veterinary Drug Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Zoetis, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Merck & Co., Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Boehringer Ingelheim International GmbH
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Bayer AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Elanco Animal Health Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Veterinary Drug Market by Animal
    • 5.1.1. Livestock
      • 5.1.1.1. Poultry
      • 5.1.1.2. Swine
      • 5.1.1.3. Cattle
      • 5.1.1.4. Aquatic
      • 5.1.1.5. Others (Sheep)
    • 5.1.2. Companion
    • 5.1.3. Other
  • 5.2. Global Veterinary Drug Market by Type
    • 5.2.1. Anti-Parasitic
    • 5.2.2. Anti-inflammatory
    • 5.2.3. Anti-infective
    • 5.2.4. Others
  • 5.3. Global Veterinary Drug Market by Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Topical
    • 5.3.3. Injection
    • 5.3.4. Other

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Akorn Animal Health, Inc.
  • 7.2. Bayer AG
  • 7.3. Bimeda Holdings PLC
  • 7.4. Biogenesis Bago A.S.
  • 7.5. BOEHRINGER Ingelheim International GmbH
  • 7.6. Ceva Sante Animale
  • 7.7. Dechra Pharmaceuticals PLC
  • 7.8. Elanco Animal Health Inc.
  • 7.9. Hipra S.A.
  • 7.10. Huvepharma EOOD
  • 7.11. Hygieia Biological Laboratories
  • 7.12. Intervet International B.V
  • 7.13. Merck & Co., Inc.
  • 7.14. Neogen Corp.
  • 7.15. Pharmgate LLC
  • 7.16. Phibro Animal Health Corp.
  • 7.17. Vetoquinol S.A.
  • 7.18. Virbac S.A.
  • 7.19. Zoetis, Inc.

LIST OF TABLES

  • 1. GLOBAL VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 2. GLOBAL LIVESTOCK DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 3. GLOBAL POULTRY DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 4. GLOBAL ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 5. GLOBAL CATTLE DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 6. GLOBAL AQUATIC DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 7. GLOBAL OTHERS LIVESTOCK ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 8. GLOBAL COMPANION ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 9. GLOBAL OTHER ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 10. GLOBAL VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 11. GLOBAL ANTI-PARASITIC DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 12. GLOBAL ANTI-INFLAMMATORY DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 13. GLOBAL ANTI-INFECTIVE DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 14. GLOBAL OTHERS DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 15. GLOBAL VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 16. GLOBAL ORAL ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 17. GLOBAL TOPICAL ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 18. GLOBAL INJECTION ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 19. GLOBAL OTHER ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 20. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 21. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 22. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 23. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 24. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 25. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 26. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 27. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 28. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 29. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 30. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 31. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 32. REST OF THE WORLD VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 33. REST OF THE WORLD VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 34. REST OF THE WORLD VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL VETERINARY DRUG MARKET SHARE BY ANIMAL, 2019 VS 2026 (%)
  • 2. GLOBAL VETERINARY DRUG MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL VETERINARY DRUG MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
  • 4. GLOBAL VETERINARY DRUG MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 5. US VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. CANADA VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. UK VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. FRANCE VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. GERMANY VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ITALY VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. SPAIN VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. REST OF EUROPE VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. INDIA VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. CHINA VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. JAPAN VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)